Corporate calendar for NewAmsterdam Pharma Company N.V. (NAMS): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | $-0.06 | |
| 2026-09-14 | $0.03 | $3M |
| 2026-09-14 | ||
| 2026-09-14 | $-0.06 | $36M |
| 2026-09-14 | $0.84 | $26M |
Price
| Price | $21.18 |
| Market Cap | $2.5B |
| Exchange | NASDAQ |
| Country | NL |
Related companies: ACLX · AKRO · CGON · CRNX · IMVT · KYMR · LGND
Explore sector: Healthcare · Biotechnology
More sections of NAMS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks